Business
Press Release Nov 08 2022
Zydus Lifesciences Limited has informed the Exchange about press release dated 08-Nov-2022 titled Zydus receives final approval from the USFDA for Bisoprolol Fumarate and Hydrochlorothiazide Tablets
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange about press release dated 08-Nov-2022 titled Zydus receives final approval from the USFDA for Bisoprolol Fumarate and Hydrochlorothiazide Tablets View Attachment","length":352,"tagName":"div"}]